超症临床试验差异:招生和报告趋势
Lauren Gawey1, Aditya Joshi1, Caitlyn B Dagenet2
1Department of Dermatology, University of Washington, Seattle, WA, USA.
Skin appendage disorders
|June 20, 2025
概括
大多数超的临床试验缺乏多样化的参与者,近一半没有报告种族或种族. 这限制了对这种过度出汗状况的研究结果的概括性.
科学领域:
- 临床试验 临床试验
- 皮肤病学 皮肤病学
- 公共卫生 公共卫生
背景情况:
- 过,一种导致过度出汗的疾病,显著影响生活质量.
- 虽然有新的治疗方法,但临床试验数据可能无法广泛应用,因为不同人群的代表性不足.
研究的目的:
- 分析地理分布,种族/民族代表性,以及在过症随机对照试验 (RCT) 中的人口统计报告.
- 为了确定多样性和报告在超研究中的趋势.
主要方法:
- 通过对ClinicalTrials.gov进行系统搜索,确定了已完成的2期和3期干预性高症RCT (2005-2024年).
- 从试验注册和出版物中提取了包括种族和种族在内的人口统计数据.
- 按大陆分析了地理表征.
主要成果:
- 包括32个涉及4,904名参与者的RCT;62.5%是美国的.
- 只有53.1%的试验报告了种族/种族,白人参与者占多数 (55.1%).
- 随着时间的推移,报告种族/民族的情况有所改善,但地理多样性下降.
结论:
- 近一半的高症RCT没有报告基本的人口统计数据.
- 试验中的有限的种族/民族和地理多样性阻碍了研究结果的概括性.
- 在超研究中,需要更具包容性的研究设计.
更多相关视频
04:53A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
10.8K
05:52Handwriting Analysis Indicates Spontaneous Dyskinesias in Neuroleptic Naïve Adolescents at High Risk for Psychosis
Published on: November 21, 2013
15.0K
相关概念视频
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Clinical Trials
9.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.3K
Hazard Ratio
261
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
261
